期刊文献+

多囊卵巢综合征患者血清脂肪细胞因子与胰岛素抵抗的相关性研究 被引量:16

Correlations between adipocytokines and insulin resistance in women with polycystic ovary syndrome
原文传递
导出
摘要 目的探讨PCOS患者血清脂肪细胞因子与胰岛素敏感性的相关性。方法将PCOS患者60例分为肥胖组PCOS36例、非肥胖组PCOS24例,将同期就诊的男方因素不孕症患者(正常体重)26例作对照组。进行内分泌代谢指标测定,采用空腹胰岛素(FINS)、胰岛素抵抗指数(HOMA-IR)评估胰岛素敏感性;并应用酶联免疫吸附法测定血清游离脂肪酸(FFA)、瘦素及C反应蛋白(CRP),放射免疫法测定血清脂联素(APN)、肿瘤坏死因子(TNF)-α、白细胞介素(IL)-6。结果(1)肥胖组PCOS的血清APN为(10±7)mg/L,低于非肥胖组PCOS[(17±9)mg/L]和对照组,均P〈0.01;FFA为(548±105)μmol/L,高于非肥胖组PCOS[(427±67)μmol/L]和对照组,P〈0.01;血清瘦素水平为(42±21)μg/L,高于非肥胖组PCOS[(24±13)μg/L]和对照组,均P〈0.01。非肥胖组PCOS与对照组问APN、FFA和瘦素差异无统计学意义。血清IL-6肥胖组PCOS[(173±184)ng/L]和非肥胖组PCOS[(184±44)ng/L]均高于对照组(P〈0.05、P〈0.01);血清TNF-α非肥胖组PCOS[(0.97±0.33)μg/L]和肥胖组PCOS[(0.82±0.21)μg/L]均高于对照组(P〈0.01,P〈0.05);非肥胖组PCOSTNF。仪高于肥胖组(P〈0.05)。非肥胖组和肥胖组的PCOS患者血清中CRP高于对照组,但差异无统计学意义(P〉0.05)。(2)瘦素与人体质量指数(BMI)、腰臀比及HOMA-IR呈正相关(P〈0.01),APN与BMI、腰臀比及HOMA-IR呈负相关(P〈0.01)。(3)BMI和TNF-α是FINS的独立影响因素,APN是除FINS、空腹血葡萄糖、BMI外,对HOMA-R的独立影响因素。结论炎性因子可能参与了非肥胖型PCOS患者IR的发生;而肥胖型PCOSIR的进一步加重可能与其脂肪组织分泌瘦素、FFA增多及分泌APN减少相关。 Objective To investigate the correlations between adipocytokines and insulin resistance in women with polycystic ovary syndrome. Methods Sixty women with polycystic ovary syndrome aged 19-34 years old were divided into 2 groups: group A [n =36, BMI ≥ 25 kg/m-2 or WHR (waist height ratio) 〉 0. 85 ] and group B ( n = 24, BMI 〈 25 kg/m-2 and WHR≤0. 85 ). Twenty-six healthy infertile women with amean age of 26±8 years old served as controls and they were named as group C (n=26, BMI 〈25 kg/m-2 and WHR ≤0. 85). Anthropometrie measurements,hormonal profiles and metabolic profiles were compared between three groups. Plasma leptin, CRP and free fatty acid were measured by enzyme-linked immunosorbent assay (ELISA). Adiponectin, interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) were measured by radioimmunoassay. Insulin resistance was estimated by homeostasis model assessment (HOMA). Results ( 1 ) Adiponectin and TNF-α levels were significantly higher in group B ( 17 ±9) mg/L and ( 1.0 ± 0. 3 ) mg/L respectively than in group A ( 10± 7 ) mg/L and ( 0. 8 ± 0. 2 ) mg/L respectively. Leptin was lower in group B ( 24 ± 13 ) μg/L and group C than in group A ( 42± 21 )μg/L ( all P 〈 0. 01 ). IL-6 was higher in group A ( 173 ± 184) ng/L and group B ( 184±44) ng/L than in group C ( P 〈 0. 05 and P 〈 0. 01respectively). No significant difference of circulating level of CRP was found between these 3 groups. (2)Leptin was positively correlated with BMI, WHR and HOMA-IR (all P 〈 0.01 ) whereas adiponectin was negatively correlated with BMI, WHR and HOMA-IR (P 〈 0. 01 ; P 〈 0. 01, P 〈 0. 05 respectively). Multivariate regression showed that adiponectin was the most significant predictor of HOMAIR and it explained 16. 5% of variance. Conclusion The higher levels of leptin and TNF-α, the lower level of adiponectin in obese PCOS and the higher level of TNF-α and IL-6 in non-obese PCOS suggested different adipocytokines play different roles of insulin resistance in PCOS. groups. (2)Leptin was positively correlated with BMI, WHR and HOMA-IR (all P 〈 0.01 ) whereas adiponectin was negatively correlated with BMI, WHR and HOMA-IR (P 〈 0. 01 ; P 〈 0. 01, P 〈 0. 05 respectively). Multivariate regression showed that adiponectin was the most significant predictor of HOMAIR and it explained 16. 5% of variance. Conclusion The higher levels of leptin and TNF-α, the lower level of adiponectin in obese PCOS and the higher level of TNF-α and IL-6 in non-obese PCOS suggested different adipocytokines play different roles of insulin resistance in PCOS.
出处 《中华医学杂志》 CAS CSCD 北大核心 2009年第37期2607-2610,共4页 National Medical Journal of China
基金 国家科技支撑项目(2007BA04804)
关键词 多囊卵巢综合征 脂肪细胞因子 脂联素 肿瘤坏死因子-Α 胰岛素抵抗 PCOS Adipocytokine Adiponectin Tumor necrosis factor-α Insulin resistance
  • 相关文献

参考文献9

  • 1Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbost Hormonal and metabolic profile. J Clin Endocrinol Metab, 1999, 84:4006-4011.
  • 2Pasquali R, Casimirri F. The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women. Clin Endocrinol,1993,39 : 1-16.
  • 3Bernard L, Christin-Maitre S, Basille C, et al. Insulin resistance and polycystic ovary syndrome. Gynecol Obstet Fertil, 2003,31: 109-116.
  • 4The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Ham Reprod, 2004,19:41-47.
  • 5傅祖植.肥胖症[A].见:叶任高.内科学第5版[C].北京:人民卫生出版社,2000.841-845.
  • 6Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985,28:412-419.
  • 7李昕,林金芳.肥胖型多囊卵巢综合征患者临床及内分泌代谢特征的研究[J].中华医学杂志,2005,85(46):3266-3271. 被引量:138
  • 8Diamanti-Kandarakis E, Paterakis T, Alexandraki K, et al. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin. Hum Reprod, 2006, 21:1426-1431.
  • 9Ridker PM, Bassuk SS, Toth PP. C-reactive protein and risk of cardiovascular disease: evidence and clinical application. Curr Atheroscler Rep, 2003,5 : 341-349.

二级参考文献17

  • 1Pantanetti P, Garrapa GG, Mantero F, et al. Adipose tissue as an endocrine organ? A review of recent data related to cardiovascular complications of endocrine dysfunctions. Clin Exp Hypertens,2004,26:387-398.
  • 2Diamanti-Kandarakis E, BergieleA. The influence of obesity on hyperandrogenism and infertility in the female. Obesity Reviews ,2001, 2:231-238.
  • 3Ciampelli M , Leoni F , Lattanzi F , et al. A pilot study of the long 2 term effects of acipimox in polycystic ovarian syndrome. Hum Reprod, 2002 ,17:647-653.
  • 4Marsden PJ , Murdoch AP , Taylor R. Tissue insulin sensitivity and body weight in polycystic ovary syndrome. Clin Endocrinol , 2001 ,55:191-199.
  • 5Dunaif A. Insulin resistance and the polycystic ovary syndrome:mechanism and implications for pathogenesis. Endocr Rev, 1997,18 : 774 - 800.
  • 6Barzilai N, Wang J, Massilon D, et al. Leptin selesctively decreases visceral adiposity and enhances insulin action. J Clin Invest, 1997,100:3105-3110.
  • 7Farah L, Lazenby A J, Boots LR, et al. Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists(Alabama Professional Electrology Association Study Group ). J Reprod Med, 1999,44:870-974.
  • 8Diamanti-Kandarakis E, Kouli CR, Bergiele AT ,et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbost hormonal and metabolic profile. J Clin Endocrinol Metab, 1999, 84: 4006-4011.
  • 9Gambineril A, Pelusil C, Vicennatil V, et al. Obesity and the polycystic ovary syndrome. Int J Obesity, 2002,26:883-896.
  • 10Pasquali R, Casimirri F. The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women. Clin Endocrinol, 1993,39: 1-16.

共引文献138

同被引文献185

引证文献16

二级引证文献122

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部